JP2006509781A5 - - Google Patents

Download PDF

Info

Publication number
JP2006509781A5
JP2006509781A5 JP2004556430A JP2004556430A JP2006509781A5 JP 2006509781 A5 JP2006509781 A5 JP 2006509781A5 JP 2004556430 A JP2004556430 A JP 2004556430A JP 2004556430 A JP2004556430 A JP 2004556430A JP 2006509781 A5 JP2006509781 A5 JP 2006509781A5
Authority
JP
Japan
Prior art keywords
methylsulfonyl
carboxamide
indole
ethyl
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004556430A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006509781A (ja
Filing date
Publication date
Priority claimed from FR0215086A external-priority patent/FR2847899B1/fr
Application filed filed Critical
Publication of JP2006509781A publication Critical patent/JP2006509781A/ja
Publication of JP2006509781A5 publication Critical patent/JP2006509781A5/ja
Pending legal-status Critical Current

Links

JP2004556430A 2002-11-29 2003-11-27 インドール−３−カルボキサミドの誘導体、それらの製造方法および治療用途 Pending JP2006509781A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0215086A FR2847899B1 (fr) 2002-11-29 2002-11-29 Derives d'indole-3-carboxamide, leur preparation et leur application en therapeutique
PCT/FR2003/003499 WO2004050086A1 (fr) 2002-11-29 2003-11-27 Derives d'indole-3-carboxamide, leur preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
JP2006509781A JP2006509781A (ja) 2006-03-23
JP2006509781A5 true JP2006509781A5 (https=) 2007-01-25

Family

ID=32309872

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004556430A Pending JP2006509781A (ja) 2002-11-29 2003-11-27 インドール−３−カルボキサミドの誘導体、それらの製造方法および治療用途

Country Status (8)

Country Link
US (1) US7202268B2 (https=)
EP (1) EP1567150B1 (https=)
JP (1) JP2006509781A (https=)
AT (1) ATE439128T1 (https=)
AU (1) AU2003294092A1 (https=)
DE (1) DE60328819D1 (https=)
FR (1) FR2847899B1 (https=)
WO (1) WO2004050086A1 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7560481B2 (en) 2004-12-21 2009-07-14 Abbott Laboratories Indoles are cannabinoid receptor ligands
FR2893615B1 (fr) * 2005-11-18 2008-03-07 Sanofi Aventis Sa Derives de 3-acylindole, leur preparation et leur application en therapeutique
US8841334B2 (en) 2006-05-31 2014-09-23 Abbvie Inc. Compounds as cannabinoid receptor ligands and uses thereof
JP2009538933A (ja) 2006-05-31 2009-11-12 アボット・ラボラトリーズ カンナビノイド受容体リガンドとしての化合物およびその使用
EP2070927A4 (en) * 2006-09-13 2010-10-13 Kyowa Hakko Kirin Co Ltd CONDENSED HETEROCYCLIC DERIVATIVE
CA2681586A1 (en) 2007-03-28 2008-10-09 Abbott Laboratories 1, 3-thiazol-2 (3h) -ylidene compounds as cannabinoid receptor ligands
US7872033B2 (en) 2007-04-17 2011-01-18 Abbott Laboratories Compounds as cannabinoid receptor ligands
EP2160393A1 (en) 2007-05-18 2010-03-10 Abbott Laboratories Novel compounds as cannabinoid receptor ligands
US9193713B2 (en) 2007-10-12 2015-11-24 Abbvie Inc. Compounds as cannabinoid receptor ligands
US8846730B2 (en) 2008-09-08 2014-09-30 Abbvie Inc. Compounds as cannabinoid receptor ligands
EP2334646A2 (en) 2008-09-16 2011-06-22 Abbott Laboratories Substituted benzamides as cannabinoid receptor ligands
WO2010077839A1 (en) * 2008-12-15 2010-07-08 Wyeth Llc (Formerly Known As Wyeth) Substituted oxindol cb2 agonists for pain treatment
PA8854001A1 (es) 2008-12-16 2010-07-27 Abbott Lab Compuestos novedosos como ligandos de receptores de canabinoides
CN108794379A (zh) * 2017-04-26 2018-11-13 华东师范大学 1h-吲哚-2-甲酰胺衍生物及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4973587A (en) * 1990-03-08 1990-11-27 Sterling Drug Inc. 3-arylcarbonyl-1-aminoalkyl-1H-indole-containing antiglaucoma method
WO2001058869A2 (en) * 2000-02-11 2001-08-16 Bristol-Myers Squibb Company Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases
FR2816938B1 (fr) * 2000-11-22 2003-01-03 Sanofi Synthelabo Derives de 3-aroylindole, leur procede de preparation et les compositions pharmaceutiques en contenant
WO2002060447A1 (en) * 2001-01-29 2002-08-08 University Of Connecticut Receptor selective cannabimimetic aminoalkylindoles

Similar Documents

Publication Publication Date Title
JP2006509781A5 (https=)
FI97224C (fi) Menetelmä terapeuttisesti käyttökelpoisten N-sulfonyyli-indoliinijohdannaisten valmistamiseksi
CN116964058A (zh) Kras g12d抑制剂及其在医药上的应用
JPS626703B2 (https=)
RS62112B1 (sr) Sinteza indazola
EP1981842A2 (fr) Derives de sulfonamides, leur preparation et leur application en therapeutique
JP2007514638A5 (https=)
JPS6147838B2 (https=)
CN110330500A (zh) 一种6β-羟基-7,8-二氢-吗啡衍生物的立体选择性合成方法
JP2006509781A (ja) インドール−３−カルボキサミドの誘導体、それらの製造方法および治療用途
ES2439258T3 (es) Derivados de azetidina, su preparación y su aplicación en terapia
CN106892863A (zh) 维莫德吉及其中间体的制备方法
CN114456086A (zh) 一种β-氰基酮的合成方法
TWI812679B (zh) 製備可溶性鳥苷酸環化酶刺激劑之方法
CN115362146B (zh) 用于生产4,5-二氢-1h-吡唑及中间体的方法
CN101010324A (zh) 吡咯并三嗪化合物的制备方法
JPH07121933B2 (ja) ジヒドロベンゾフラノン誘導体
CN103664686A (zh) α-羟基烯基叠氮类化合物的合成方法
CN105037160A (zh) 一种制备维生素b1中间体的方法
CN110845445A (zh) 一种连接体及制备方法和应用、基于沙利度胺的PROTACs的中间体及应用
CN113402445B (zh) 一种制备咔唑类化合物和二苯并噻吩类化合物的方法
CN101384546A (zh) 用于制备酰胺的方法
WO2006129781A1 (ja) ジベンズオキセピン誘導体の製造方法
JPS5811863B2 (ja) ５−（４；− クロロ −ｎ− ブチル ） ピコリンサンアミドノセイゾウホウ
JPS58140065A (ja) メルカプトベンジル脂肪酸誘導体類及びその製法